LFA Development: Transfer to Manufacture

Successful transfer of Lateral Flow Assay manufacturing is a critical step toward scalable, compliant production. At Fleet Bioprocessing Ltd., we integrate manufacturability and process robustness considerations from early assay development, ensuring your design is production ready well before formal transfer begins.

With extensive experience alongside industry leaders, Fleet applies its expertise to transfer your Lateral Flow Assay design into internal facilities, contract manufacturers, or OEM partners. We provide hands on support for training, pilot, and process validation batches to ensure smooth scale up. At the same time, we can manufacture critical reagents such as conjugates and other key assay components in house at scale, supplying high quality materials to support your assay production.

Our consultancy services provide strategic guidance to optimise LFA manufacturing scale up, improve process efficiency, and navigate technical transfer challenges. We can help reduce costs, increase yields, and accelerate time to market through tailored advice on automation, equipment sourcing, and robust process design.

Contact us today to discuss how our transfer to manufacture services can support your Lateral Flow Assay production goals.